Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Insulin Lispro Atc A10Ab04 And A10Ad04 For The Period January 1St 2026 December 31St 2027

Deadline: 05 Nov 2027

Germany

Ref. No.: 22371392

EMD:Ref Document

Bid Value: Ref Document

356 Days Left

Open House Procedure Outpatient Vein Therapy

Deadline: 30 Nov 2027

Germany

Ref. No.: 22370755

EMD:Ref Document

Bid Value: Ref Document

381 Days Left

Management Of Waste Produced On The Various Sites Of The Brest Lorient Defense Base

Deadline: 01 Dec 2026

France

Ref. No.: 22369599

EMD:Ref Document

Bid Value: Ref Document

17 Days Left

Catering Services For The Eurometropole Of Metz

Deadline: 01 Dec 2026

France

Ref. No.: 22369563

EMD:Ref Document

Bid Value: Ref Document

17 Days Left

Management And Operation Of The Public Drinking Water Service

Deadline: 01 Dec 2026

France

Ref. No.: 22369541

EMD:Ref Document

Bid Value: Ref Document

17 Days Left

Open House Drug Discount Agreements Pazopanib Atc L01Ex03

Deadline: 03 Nov 2027

Germany

Ref. No.: 22368732

EMD:Ref Document

Bid Value: Ref Document

354 Days Left

Medicine Discount Contracts In Accordance With Section 130A Paragraph 8 Sgb V As Part Of Open House Procedures

Deadline: 05 Nov 2027

Germany

Ref. No.: 22368719

EMD:Ref Document

Bid Value: Ref Document

356 Days Left

Open House Discount Contracts 2025 15

Deadline: 31 Dec 2027

Germany

Ref. No.: 22368717

EMD:Ref Document

Bid Value: Ref Document

412 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Guanfacine Atc N06Ba21 For The Period January 1St 2026 December 31St 2027 Plus Extension Option 1X12 Months

Deadline: 05 Nov 2028

Germany

Ref. No.: 22368602

EMD:Ref Document

Bid Value: Ref Document

722 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tildrakizumab Atc L04Ac17 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22368587

EMD:Ref Document

Bid Value: Ref Document

352 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dimethyl Fumarate Atc D05Bx02 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22368580

EMD:Ref Document

Bid Value: Ref Document

352 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab Atc D11Ah10 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22368576

EMD:Ref Document

Bid Value: Ref Document

352 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Insulin Lispro Atc A10Ab04 And A10Ad04 For The Period January 1St 2026 December 31St 2027

Deadline: 05 Nov 2027

Germany

Ref. No.: 22368571

EMD:Ref Document

Bid Value: Ref Document

356 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Buserelin Atc L02Ae01 For The Period January 1St 2026 December 31St 2027

Deadline: 05 Nov 2027

Germany

Ref. No.: 22368565

EMD:Ref Document

Bid Value: Ref Document

356 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Paliperidone Exclusively 3 Month Depot Atc N05Ax13 For The Period January 1St 2026 December 31St 2027

Deadline: 05 Nov 2027

Germany

Ref. No.: 22368560

EMD:Ref Document

Bid Value: Ref Document

356 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!